Paracrine VEGF/VE-Cadherin Action on Ovarian Cancer Permeability
暂无分享,去创建一个
[1] E. Dejana,et al. Perspectives Series: Cell Adhesion in Vascular Biology Endothelial Adherens Junctions: Implications in the Control of Vascular Permeability and Angiogenesis , 1996 .
[2] R K Jain,et al. Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.
[3] Bing Li,et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.
[4] P. Hordijk,et al. Vascular-endothelial-cadherin modulates endothelial monolayer permeability. , 1999, Journal of cell science.
[5] F. Liao,et al. Vascular Endothelial Cadherin (VE‐Cadherin): Cloning and Role in Endothelial Cell‐Cell Adhesion , 1997, Microcirculation.
[6] S. Vilaró,et al. Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability , 2003, The European journal of neuroscience.
[7] J. Alexander,et al. Organ preservation solutions increase endothelial permeability and promote loss of junctional proteins. , 1999, Annals of surgery.
[8] G. Yancopoulos,et al. Vascular endothelial growth factor-trap decreases tumor burden, inhibits ascites, and causes dramatic vascular remodeling in an ovarian cancer model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] D. Marmé,et al. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease , 1999, Cancer.
[10] Y. Rui,et al. Inhibitory effect of extracts of Ginkgo biloba leaves on VEGF-induced hyperpermeability of bovine coronary endothelial cells in vitro. , 2004, Acta pharmacologica Sinica.
[11] L. Ellis,et al. Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. , 2003, Cancer research.
[12] D. Horsfall,et al. A potential autocrine role for vascular endothelial growth factor in prostate cancer. , 2002, Cancer research.
[13] N. Ferrara,et al. Vascular endothelial growth factor immunoneutralization plus Paclitaxel markedly reduces tumor burden and ascites in athymic mouse model of ovarian cancer. , 2002, The American journal of pathology.
[14] Gordon B. Mills,et al. Markedly Elevated Levels of Vascular Endothelial Growth Factor in Malignant Ascites , 1999, Annals of Surgical Oncology.
[15] A. Gamero,et al. Angiogenic protein expression in advanced epithelial ovarian cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] C. Bucana,et al. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. , 1998, Journal of the National Cancer Institute.
[17] H. Dvorak,et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. , 1995, Cancer research.
[18] M. Corada,et al. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[19] M. Perrot-Applanat,et al. Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation , 2004, Angiogenesis.
[20] J. Folkman,et al. Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen , 1995 .
[21] N. Ferrara,et al. Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. , 1998, The American journal of pathology.
[22] E. Ezan,et al. A co-culture-based model of human blood–brain barrier: application to active transport of indinavir and in vivo–in vitro correlation , 2002, Brain Research.
[23] Y. Meng,et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. , 1996, The Journal of clinical endocrinology and metabolism.
[24] J. Alexander,et al. Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.